157 related articles for article (PubMed ID: 12011379)
21. Anticardiolipin, other antiphospholipid antibody tests and diagnosis of the antiphospholipid syndrome.
Smikle M; Wharfe G; Fletcher H; Reid M; Roye-Green K; Fredrick J; Pierangeli S
Hum Antibodies; 2003; 12(3):63-6. PubMed ID: 14646034
[TBL] [Abstract][Full Text] [Related]
22. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies.
Nash MJ; Camilleri RS; Kunka S; Mackie IJ; Machin SJ; Cohen H
J Thromb Haemost; 2004 Jul; 2(7):1077-81. PubMed ID: 15219190
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.
Vlachoyiannopoulos PG; Petrovas C; Tektonidou M; Krilis S; Moutsopoulos HM
J Clin Immunol; 1998 Nov; 18(6):380-91. PubMed ID: 9857282
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
27. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J
J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
[TBL] [Abstract][Full Text] [Related]
28. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
[TBL] [Abstract][Full Text] [Related]
29. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
30. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
31. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein.
Hörkkö S; Olee T; Mo L; Branch DW; Woods VL; Palinski W; Chen PP; Witztum JL
Circulation; 2001 Feb; 103(7):941-6. PubMed ID: 11181467
[TBL] [Abstract][Full Text] [Related]
32. Clinical laboratory testing for the antiphospholipid syndrome.
Pierangeli SS; Harris EN
Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301
[TBL] [Abstract][Full Text] [Related]
33. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
34. Optimising testing for phospholipid antibodies.
Helbert M; Bodger S; Cavenagh J; D'Cruz D; Thomas JM; MacCallum P
J Clin Pathol; 2001 Sep; 54(9):693-8. PubMed ID: 11533076
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
Decavele AS; Schouwers S; Devreese KM
Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
[TBL] [Abstract][Full Text] [Related]
36. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
Lee RM; Emlen W; Scott JR; Branch DW; Silver RM
Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478
[TBL] [Abstract][Full Text] [Related]
37. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
[TBL] [Abstract][Full Text] [Related]
38. Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies.
El-Kadi HS; Keil LB; DeBari VA
J Rheumatol; 1995 Dec; 22(12):2233-7. PubMed ID: 8835554
[TBL] [Abstract][Full Text] [Related]
39. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
